Very Early Detection of Alzheimer Neuropathology and the Role of Brain Reserve in Modifying Its Clinical Expression

Journal of Geriatric Psychiatry and Neurology - Tập 18 Số 4 - Trang 218-223 - 2005
James A. Mortimer1, Amy R. Borenstein2, Karen M. Gosche3, David A. Snowdon4
1Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL 33612-3899, USA.
2Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL
3NeuroImaging Research, Alachua, FL
4Sanders-Brown Center on Aging and Department of Neurology, University of Kentucky, Lexington, KY

Tóm tắt

Numerous studies show that the pathology of Alzheimer’s disease is present decades before a clinical diagnosis of dementia can be made. Given the likelihood that agents will become available that reliably delay onset and/or slow progression of Alzheimer’s disease, it will be important to detect preclinical Alzheimer’s disease as early as possible for maximal treatment effect. Detection of individuals by sensitive cognitive measures provides one way to identify people who are at high risk of developing clinical Alzheimer’s disease. However, it is likely that those with considerable brain or cognitive reserve will be able to mask cognitive deficits until very close to the onset of the dementia, rendering such cognitive measures insensitive. Optimum biomarkers for Alzheimer’s disease therefore need to target the severity of underlying brain pathology independently of brain reserve. Findings are presented showing the importance of higher education and larger brain size in masking the underlying disease pathology.

Từ khóa


Tài liệu tham khảo

10.1016/S0197-4580(97)00056-0

10.2190/DV3R-PBJQ-E0FT-7W2B

10.1001/archneur.1995.00540290075020

10.1001/archneur.57.6.808

10.1212/01.WNL.0000055813.36504.BF

10.1001/jama.1996.03530310034029

10.3233/JAD-2002-4307

10.1093/gerona/52A.2.M117

10.1001/archpsyc.1997.01830150090013

10.1056/NEJM199511093331902

10.1212/WNL.56.12.1696

10.1016/j.neurobiolaging.2003.12.023

10.1016/S0197-4580(00)82822-5

10.1212/WNL.38.11.1682

10.1002/ana.410230206

10.1016/S0140-6736(00)03589-3

10.1001/jama.1997.03540340047031

Dartigues JF, 1991, Rev Neurol, 147, 225

10.1007/s12031-002-0040-4

10.1001/archneur.1996.00550020038013

10.1017/S1041610298005456

10.1212/WNL.50.5.1231

10.1046/j.1532-5415.2003.51054.x

10.3109/00048679809113126

Kokmen E, 1993, Neurology, 43, A317, 10.1212/WNL.43.10.1887

10.1136/bmj.310.6985.970

10.1136/jnnp.60.6.628

10.1159/000064930

10.1016/S0895-4356(97)00121-2

10.1002/ana.410270412

10.1046/j.1532-5415.2002.50006.x

10.1001/archneur.1997.00550230066019

10.1212/WNL.48.1.132

10.1093/aje/kwh018

10.1212/WNL.52.1.78

10.1136/jnnp.66.2.177

10.1093/aje/kwf074

10.1212/WNL.52.3.663

10.1001/jama.1994.03510370056032

10.1212/01.WNL.0000036905.59156.A1

10.1111/j.1440-1819.1998.tb03248.x

10.1212/WNL.42.11.2063

10.1212/WNL.45.9.1707

10.1093/oxfordjournals.aje.a009000

10.1136/adc.48.10.757

10.1176/ajp.154.1.18

10.1001/archneur.1995.00540250103019

10.1002/gps.1205

10.1192/bjp.169.1.86

10.1212/WNL.53.1.228

10.1212/WNL.49.1.30

10.1212/WNL.57.8.1453

10.1212/WNL.59.2.272

10.1001/archneur.57.2.220

10.1017/S1041610294001602

10.1076/jcen.25.5.671.14584

10.1212/01.WNL.0000069923.64550.9F

10.1002/ana.10161

Gosche KM, 2001, AJNR, 22, 1686

10.1212/WNL.58.5.750

10.1212/WNL.58.10.1476